CIK 0001370053
- Non-accelerated filer
- Smaller reporting company
ANAPTYSBIO, INC
Sign in to watch- Ticker
- ANAB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 203828755
- Phone
- +1 858-362-6295
- Business address
- 10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA, 92121
- Former names
- ANAPTYSBIO INC, ANAPTYS BIOSCIENCES INC
- Open-market buys, last 90 days
- $17,224,593
- in 1 filing
- Open-market sales, last 90 days
- $249,372
- in 1 filing, $249K under 10b5-1 plans
Net +$16,975,221. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-08 | MULROY DENNIS CHIEF FINANCIAL OFFICER | Sale | −2,515 | $44.71 | $112K | 21,852 |
| 2026-01-07 | MULROY DENNIS CHIEF FINANCIAL OFFICER | Exercise or conversion | +6,700 | 24,367 | ||
| 2026-01-07 | MULROY DENNIS CHIEF FINANCIAL OFFICER | Exercise or conversion · Restricted Stock Unit | −6,700 | 20,100 | ||
| 2026-01-07 | MULROY DENNIS CHIEF FINANCIAL OFFICER | Sale | −1,908 | $45.11 | $86K | 17,667 |
| 2026-01-06 | MULROY DENNIS CHIEF FINANCIAL OFFICER | Exercise or conversion | +5,245 | 19,575 | ||
| 2026-01-06 | MULROY DENNIS CHIEF FINANCIAL OFFICER | Exercise or conversion · Restricted Stock Unit | −5,245 | 5,245 | ||
| 2026-01-06 | MULROY DENNIS CHIEF FINANCIAL OFFICER | Grant or award · Restricted Stock Unit | +21,400 | 21,400 | ||
| 2026-01-06 | MULROY DENNIS CHIEF FINANCIAL OFFICER | Grant or award · Stock Option (right to buy) | +29,000 | 29,000 | ||
| 2026-01-05 | MULROY DENNIS CHIEF FINANCIAL OFFICER | Sale | −3,363 | $43.26 | $145K | 14,330 |
| 2026-01-03 | MULROY DENNIS CHIEF FINANCIAL OFFICER | Exercise or conversion | +8,292 | 17,693 | ||
| 2026-01-03 | MULROY DENNIS CHIEF FINANCIAL OFFICER | Exercise or conversion · Restricted Stock Unit | −8,292 | 16,585 | ||
| 2025-12-22 | MULROY DENNIS CHIEF FINANCIAL OFFICER | Exercise or conversion 10b5-1 | +10,000 | $20.16 | $202K | 19,401 |
| 2025-12-22 | MULROY DENNIS CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −10,000 | $50.00 | $500K | 9,401 |
| 2025-12-22 | MULROY DENNIS CHIEF FINANCIAL OFFICER | Exercise or conversion · Employee Stock Option (right to buy) 10b5-1 | −10,000 | 60,600 | ||
| 2025-12-16 | MULROY DENNIS CHIEF FINANCIAL OFFICER | Exercise or conversion 10b5-1 | +10,000 | $20.16 | $202K | 25,126 |
| 2025-12-16 | MULROY DENNIS CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −9,365 | $44.62 | $418K | 15,761 |
| 2025-12-16 | MULROY DENNIS CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −6,360 | $45.21 | $288K | 9,401 |
| 2025-12-16 | MULROY DENNIS CHIEF FINANCIAL OFFICER | Exercise or conversion · Employee Stock Option (right to buy) 10b5-1 | −10,000 | 70,600 | ||
| 2025-01-07 | MULROY DENNIS CHIEF FINANCIAL OFFICER | Grant or award · Restricted Stock Unit | +26,800 | 26,800 | ||
| 2025-01-07 | MULROY DENNIS CHIEF FINANCIAL OFFICER | Grant or award · Stock Option (right to buy) | +76,400 | 76,400 |
Page 1 of 3 · 52 trades